Morgan Stanley Lowers Eli Lilly and Company (NYSE:LLY) Price Target to $1,124.00
Eli Lilly and Company (NYSE:LLY – Get Free Report) had its target price reduced by investment analysts at Morgan Stanley from $1,146.00 to $1,124.00 in a research report issued on Wednesday,Benzinga reports. The brokerage presently has an “overweight” rating on the stock. Morgan Stanley’s target price indicates a potential upside of 56.14% from the stock’s […]
Eli Lilly and Company (NYSE:LLY – Get Free Report) had its target price reduced by investment analysts at Morgan Stanley from $1,146.00 to $1,124.00 in a research report issued on Wednesday,Benzinga reports. The brokerage presently has an “overweight” rating on the stock. Morgan Stanley’s target price indicates a potential upside of 56.14% from the stock’s […]
